17 September 2019PatentsIain Armstrong

Immunotherapy patents: Why CAR-T is driving up patent activity

Immunotherapies are a hugely promising therapeutic area, in terms of both clinical benefits and potential market size. These treatments augment the body’s own immune response to improve its effectiveness in fighting diseases, particularly cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Huawei wins seven-country ban on Netgear routers at the UPC

Lenovo faces US import ban as ITC sides with Ericsson

Arusha Protocol takes root: Fresh growth for plant variety protection in Africa

‘The politics of AI are developing’: Will Trump give tech a free ride?

China: Unpacking the first successful patent invalidation due to unauthorised foreign filing

SharkNinja overturns Dyson’s vacuum ban at the UPC

On our radar… Smashburger, OpenAI, Feminist Cyberlaw

IP strategy for AI should be a ‘living, breathing organism’

Immunotherapy patents: Why CAR-T is driving up patent activity

More on this story

Editor's picks

Editor's picks

More articles